#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4190499	B	Proteolysis targeting chimera activity in human K562 cells assessed as induction of cereblon-mediated delivery of BCR-ABL for protein degradation by proteasome at 1 uM after 24 hrs by immuno blot analysis relative to control	Homo sapiens	2	ALA4190166	cell-based format	Scientific Literature
2.	ALA4382069	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels at 100 nM incubated for 36 hrs by Western blot analysis	Homo sapiens	2	ALA4376901	cell-based format	Scientific Literature
3.	ALA4382081	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels pre-treated with ABL inhibitor dasatinib followed by compound addition at 250 nM incubated for 24 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
4.	ALA4382083	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels at 50 to 250 nM incubated for 24 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
5.	ALA4382085	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels pre-treated with lenalidomide followed by compound addition at 250 nM incubated for 24 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
6.	ALA4382087	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels pre-treated with NEDD8-activating enzyme (NAE) inhibitor MLN4924 followed by compound addition at 250 nM incubated for 24 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
7.	ALA4382089	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels incubated for 36 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
8.	ALA4382091	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels at 500 nM incubated for 36 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
9.	ALA4382093	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels at 250 nM incubated for 4 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
10.	ALA4382095	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels at 250 nM incubated for 10 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
11.	ALA4382097	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels at 250 nM incubated for 32 hrs by Western blot analysis	Homo sapiens	2	ALA4376901	cell-based format	Scientific Literature
12.	ALA4382100	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels incubated for 24 hrs followed by exposure to UV-C light every 4 hrs by Western blot analysis	Homo sapiens	1	ALA4376901	cell-based format	Scientific Literature
13.	ALA4382102	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels incubated for 24 hrs followed by exposure to white light up to 24 hrs hrs by Western blot analysis	Homo sapiens	2	ALA4376901	cell-based format	Scientific Literature
14.	ALA4619594	B	Protac activity at Cereblon/BCR/ABL in human K562 cells assessed as induction of BCR-ABL degradation incubated for 32 to 48 hrs by Western blot analysis	Homo sapiens	20	ALA4616725	cell-based format	Scientific Literature
15.	ALA4619596	B	Protac activity at Cereblon/BCR/ABL T315I mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in BCR-ABL T315I mutant protein levels at 3 to 30000 nM incubated for 32 hrs by Western blot analysis	Homo sapiens	2	ALA4616725	cell-based format	Scientific Literature
16.	ALA4619598	B	Protac activity at Cereblon/BCR/ABL T315I mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in BCR-ABL T315I mutant driven cell viability incubated for 3 days by CCK8 assay	Homo sapiens	16	ALA4616725	cell-based format	Scientific Literature
17.	ALA4619599	B	Protac activity at Cereblon/BCR/ABL E255K mutant (unknown origin) expressed in human HeLa cells cells assessed as reduction in BCR-ABL E255K mutant protein levels at 10 to 10000 nM incubated for 32 hrs by Western blot analysis	Homo sapiens	1	ALA4616725	cell-based format	Scientific Literature
18.	ALA4619600	B	Protac activity at Cereblon/BCR/ABL H396R mutant (unknown origin) expressed in human HeLa cells cells assessed as reduction in BCR-ABL H396R mutant protein levels at 10 to 10000 nM incubated for 32 hrs by Western blot analysis	Homo sapiens	1	ALA4616725	cell-based format	Scientific Literature
19.	ALA4619601	B	Protac activity at Cereblon/BCR/ABL V468F mutant (unknown origin) expressed in human HeLa cells cells assessed as reduction in BCR-ABL V468F mutant protein levels at 10 to 10000 nM incubated for 32 hrs by Western blot analysis	Homo sapiens	1	ALA4616725	cell-based format	Scientific Literature
20.	ALA4619602	B	Protac activity at Cereblon/BCR/ABL T315I mutant (unknown origin) expressed in mouse BaF3 cells assessed as reduction in BCR-ABL T315I mutant protein levels at 3 to 30000 nM incubated for 48 hrs by Western blot analysis	Homo sapiens	3	ALA4616725	cell-based format	Scientific Literature